Gastrointestinal Bleeding Treatment Devices Market Is Expected To Offer Substantial Growth Opportunities, Reaching $1.39 Billion By 2030
What Is The Expected Valuation Of The Gastrointestinal Bleeding Treatment Devices Market In The Upcoming Years, And How Quickly Is It Set To Grow?
The gastrointestinal bleeding treatment devices market size has grown strongly in recent years. It will grow from $0.92 billion in 2025 to $1 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal disorders, rising prevalence of peptic ulcer disease, expansion of endoscopic diagnostic procedures, growing hospital-based gi interventions, availability of advanced endoscopy equipment.
The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation endoscopic devices, rising demand for outpatient gi procedures, growing focus on early bleeding detection, expansion of ambulatory surgical centers, increasing investments in advanced gi care technologies. Major trends in the forecast period include increasing adoption of advanced endoscopic hemostasis devices, rising use of minimally invasive gi bleeding treatments, growing demand for precision thermal ablation tools, expansion of mechanical hemostatic solutions, enhanced focus on rapid bleeding control technologies.
Claim Your Free Report Sample Today:
Which Major Drivers Are Accelerating Expansion Within The Gastrointestinal Bleeding Treatment Devices Market?
The increasing burden of gastrointestinal disorders is expected to make the market more lucrative. Gastrointestinal diseases can be caused due to a low fiber diet, being stressed, not drinking enough water, eating a lot of dairy foods, inactive lifestyle, aging, and genetic factors. For instance, in October 2024, according to the National Library of Medicine, a US-based national library, reported in 2023, an 825 per 100,000 Canadians have inflammatory bowel disease (IBD), affecting over 320,000 individuals, with projections indicating this number could rise to 1.1% of the population, or around 470,000 Canadians, by 2035. Therefore, increase in prevalence of disorders related to GI tract is driving the market.
Which Segments Are Expected To Shape The Future Direction Of The Gastrointestinal Bleeding Treatment Devices Market?
The gastrointestinal bleeding treatment devices market covered in this report is segmented –
1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices
2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices
3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems
4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents
5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms
What Trends Are Driving Change Across The Gastrointestinal Bleeding Treatment Devices Market Landscape?
Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on developing advanced solutions, such as Hemospray to enhance the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray is a hemostatic powder designed to manage and control active bleeding in the gastrointestinal (GI) tract. For instance in January 2024, AIG Hospitals, a India -based hospital launched Hemospray, a breakthrough in controlling GI bleeding. Hemospray is a hemostatic agent specifically designed for use in endoscopic procedures to control acute gastrointestinal (GI) bleeding. Hemospray is notable for its ease of use, safety profile, and ability to control a wide variety of GI bleeds, from peptic ulcers to variceal hemorrhages.
Who Are The Companies Setting The Competitive Benchmark In The Gastrointestinal Bleeding Treatment Devices Market?
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC
Get Your In-Depth Gastrointestinal Bleeding Treatment Devices Market Report Now:
Which Region Currently Accounts For The Largest Share Of The Gastrointestinal Bleeding Treatment Devices Market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment